CEL-SCI Corporation (CVM) Key Metrics
CVM valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $31.5M
- Enterprise value
- $30.9M
- P/E (TTM)
- —
- Forward P/E
- 23.0
- PEG ratio
- 1.12
- Price / sales
- 92.9
- Price / book
- 2.4
- EV / EBITDA
- 11.0
- Dividend yield
- —
- Beta
- 0.59
CVM key metrics, FY2016–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsCVM valuation Price multiples at each fiscal year-end price.
CVM returns How much profit the business earns on the capital it uses.
CVM per-share figures Results divided by the shares outstanding at year-end.
CVM financial health Debt, liquidity and how easily interest is covered.
CVM efficiency & capital use Working capital cycle and where the cash goes.
CVM valuation history
CVM returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CVM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CVM price vs earnings per share
CVM key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $37.3M | — | — | — | — | — | $8.36B | $2.07B | $393.6M | $1.13B |
| Enterprise value | $35.7M | — | — | — | — | — | $8.37B | $2.07B | $405.4M | $1.14B |
| Price / book | 2.3 | — | — | — | — | — | — | — | — | — |
| Earnings yield | −68.1% | — | — | — | — | — | −0.3% | −1.5% | −3.6% | −1.0% |
| Free cash flow yield | −46.0% | — | — | — | — | — | −0.2% | −0.7% | −3.5% | −2.0% |
| Dividend yield | — | — | — | — | — | — | — | 0.0% | 0.0% | — |
| Shareholder yield (dividends + buybacks) | 0.0% | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
| Share price at fiscal year-end | $9.20 | $31.80 | $37.50 | $92.70 | $329.70 | $382.50 | $268.20 | $121.50 | $49.80 | $232.50 |
| Per share | ||||||||||
| Revenue per share | $0.00 | — | — | — | — | — | $0.01 | $0.03 | $0.01 | $0.06 |
| Earnings per share | −$6.27 | — | — | — | — | — | −$0.79 | −$1.87 | −$1.82 | −$2.36 |
| Operating cash flow per share | −$4.22 | — | — | — | — | — | −$0.52 | −$0.79 | −$1.75 | −$4.74 |
| Free cash flow per share | −$4.23 | — | — | — | — | — | −$0.53 | −$0.79 | −$1.75 | −$4.75 |
| Cash per share | $2.70 | — | — | — | — | — | $0.27 | $0.61 | $0.30 | $0.60 |
| Book value per share | $3.93 | — | — | — | — | — | $0.16 | $0.00 | −$0.42 | −$0.20 |
| Tangible book value per share | $3.90 | — | — | — | — | — | $0.15 | −$0.02 | −$0.45 | −$0.25 |
| Dividends per share | — | — | — | — | — | — | — | $0.00 | $0.00 | — |
| Capex per share | $0.01 | — | — | — | — | — | $0.01 | $0.00 | $0.00 | $0.01 |
| Debt per share | $2.31 | — | — | — | — | — | $0.44 | $0.84 | $1.80 | $2.73 |
| Shares outstanding | 4.1M | — | — | — | — | — | 31.2M | 17.0M | 7.9M | 4.9M |
| Change in shares outstanding | — | — | — | — | — | — | +83.3% | +115.2% | +62.4% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −176.3% | −206.4% | −142.6% | −82.8% | −95.4% | −243.6% | −961.8% | — | — | — |
| Return on invested capital (ROIC) | −114.8% | −98.2% | −104.8% | −103.4% | −118.0% | −160.8% | −224.1% | −213.5% | −188.4% | −323.5% |
| Return on assets (ROA) | −92.2% | −93.6% | −79.9% | −58.1% | −62.5% | −88.8% | −86.3% | −121.3% | −83.2% | −84.8% |
| Return on tangible assets | −90.6% | −100.4% | −106.7% | −72.9% | −48.1% | −75.3% | −90.4% | −108.6% | −63.3% | −101.1% |
| Financial health | ||||||||||
| Total debt | $9.4M | $11.6M | $13.6M | $15.3M | $16.0M | $13.9M | $13.6M | $14.2M | $14.2M | $13.3M |
| Cash & short-term investments | $11.0M | $4.7M | $4.1M | $22.7M | $42.2M | $15.5M | $8.4M | $10.3M | $2.4M | $2.9M |
| Net debt | −$1.6M | $6.9M | $9.4M | −$7.4M | −$26.2M | −$1.6M | $5.2M | $3.9M | $11.8M | $10.4M |
| Debt / equity | 0.59 | 0.90 | 1.03 | 0.48 | 0.28 | 0.71 | 2.66 | — | — | — |
| Debt / assets | 0.33 | 0.43 | 0.44 | 0.30 | 0.21 | 0.34 | 0.49 | 0.48 | 0.62 | 1.14 |
| Current ratio | 2.26 | 1.31 | 1.24 | 5.45 | 11.50 | 4.15 | 3.25 | 1.24 | 0.39 | 1.47 |
| Quick ratio | 2.20 | 1.09 | 0.84 | 5.02 | 10.99 | 3.96 | 2.99 | 1.17 | 0.33 | 1.22 |
| Interest coverage | -38.2 | -35.3 | -46.6 | -33.4 | -31.5 | -28.0 | -11.2 | — | -5.3 | — |
| Working capital | $6.5M | $1.4M | $1.3M | $20.8M | $41.3M | $13.4M | $6.8M | $2.2M | −$6.6M | $1.9M |
| Invested capital | $14.4M | $19.8M | $22.6M | $24.8M | $30.3M | $18.2M | $10.3M | $3.9M | $8.5M | $9.4M |
| Tangible asset value | $15.8M | $12.7M | $13.0M | $32.0M | $56.3M | $19.4M | $4.8M | −$257,177 | −$3.6M | −$1.2M |
| Net current asset value | −$602,535 | −$8.1M | −$10.4M | $7.1M | $25.9M | −$3.1M | −$12.7M | −$18.1M | −$22.0M | −$6.7M |
| Graham net-net per share | −$0.27 | — | — | — | — | — | −$0.44 | −$1.11 | −$2.96 | −$1.82 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | $0 | $0 | — |
| Share buybacks (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Capex / revenue | — | — | — | — | — | 482.4% | 72.6% | 12.2% | 24.6% | 12.0% |
| Capex / depreciation | 0.01 | 0.02 | 0.09 | 0.17 | 4.05 | 1.25 | 0.53 | 0.09 | 0.03 | 0.23 |
| Stock-based compensation / revenue | — | — | — | — | — | 1,839.4% | 988.0% | 606.1% | 2,219.4% | 798.1% |
| R&D / revenue | — | — | — | — | — | 3,193.4% | 2,735.6% | 1,972.6% | 22,612.3% | 6,788.8% |
| SG&A / revenue | — | — | — | — | — | 2,094.9% | 1,728.5% | 1,646.9% | 8,403.9% | 2,275.5% |
| Efficiency | ||||||||||
| Days sales outstanding | — | — | — | — | — | 38.4 | 71.5 | 129.1 | 1,620.9 | 308.4 |
| Days of inventory on hand | 15.2 | 150.3 | 34.5 | 188.4 | 1,033.8 | 16.4 | 20,581.2 | 22,035.1 | 484.7 | 25,217.1 |
| Days payables outstanding | 28.8 | 159.0 | 29.5 | 154.8 | 1,352.8 | 36.9 | 105,679.5 | 233,103.8 | 3,254.4 | 85,995.2 |
| Cash conversion cycle (days) | — | — | — | — | — | 17.9 | -85,026.7 | -210,939.6 | -1,148.8 | -60,469.6 |
| Receivables turnover | — | — | — | — | 0.00 | 9.49 | 5.10 | 2.83 | 0.23 | 1.18 |
| Payables turnover | 12.66 | 2.30 | 12.39 | 2.36 | 0.27 | 9.89 | 0.00 | 0.00 | 0.11 | 0.00 |
| Inventory turnover | 24.01 | 2.43 | 10.58 | 1.94 | 0.35 | 22.27 | 0.02 | 0.02 | 0.75 | 0.01 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.00 | 0.02 |
| Average receivables | — | — | — | −$973,396 | $54,922 | $58,844 | $90,711 | $168,569 | $306,498 | $240,864 |
| Average payables | $1.3M | $1.7M | $1.8M | $1.6M | $1.8M | $1.8M | $3.7M | $7.0M | $5.6M | $4.1M |
| Average inventory | $661,595 | $1.6M | $2.1M | $2.0M | $1.4M | $801,208 | $713,800 | $658,880 | $840,582 | $1.2M |
| Intangibles / total assets | 0.4% | 0.6% | 0.6% | 0.4% | 0.4% | 0.8% | 1.1% | 0.9% | 1.0% | 2.2% |
Computed from CVM's annual financial statements (latest annual report filed December 29, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CVM valuation and financial ratios
CEL-SCI earned a return on equity of −176.3% and a return on invested capital of −114.8% in fiscal 2025. It ended the year with $9.4 million of debt and $11.0 million in cash and short-term investments, a net cash position of $1.6 million. The share count fell 16.7% from 4.9M to 4.1M over 9 years.
See the CVM income statement, the CVM chart for price history, or the CVM stock overview for the latest quote and news.
CVM key metrics FAQ
What is CEL-SCI's return on equity?
CEL-SCI's return on equity (ROE) was −176.3% in fiscal 2025: net income of -$25.4 million on average shareholders' equity of $14.4 million.
What is CEL-SCI's ROIC?
CEL-SCI's return on invested capital was −114.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does CEL-SCI have?
CEL-SCI had total debt of $9.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.59 and more cash than debt.
What is CEL-SCI's free cash flow yield?
CEL-SCI generated -$17.2 million of free cash flow in fiscal 2025, a free cash flow yield of −46.0% on its market value at year-end ($37.3 million).
What is CEL-SCI's current ratio?
CEL-SCI's current ratio was 2.26 at the end of fiscal 2025: current assets were 2.26 times current liabilities.